112 related articles for article (PubMed ID: 2827077)
1. The neurotoxin MPTP does not affect striatal superoxide dismutase activity in mice.
Pikarsky E; Melamed E; Rosenthal J; Uzzan A; Michowiz SD
Neurosci Lett; 1987 Dec; 82(3):327-31. PubMed ID: 2827077
[TBL] [Abstract][Full Text] [Related]
2. Effect of intrastriatal and intranigral administration of synthetic neuromelanin on the dopaminergic neurotoxicity of MPTP in rodents.
Melamed E; Soffer D; Rosenthal J; Pikarsky E; Reches A
Neurosci Lett; 1987 Dec; 83(1-2):41-6. PubMed ID: 3502019
[TBL] [Abstract][Full Text] [Related]
3. Systemic administration of antioxidants does not protect mice against the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP).
Martinovits G; Melamed E; Cohen O; Rosenthal J; Uzzan A
Neurosci Lett; 1986 Aug; 69(2):192-7. PubMed ID: 3489911
[TBL] [Abstract][Full Text] [Related]
4. Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity.
Przedborski S; Kostic V; Jackson-Lewis V; Naini AB; Simonetti S; Fahn S; Carlson E; Epstein CJ; Cadet JL
J Neurosci; 1992 May; 12(5):1658-67. PubMed ID: 1578260
[TBL] [Abstract][Full Text] [Related]
5. Dopamine-releasing action of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and 1-methyl-4-phenylpyridine (MPP+) in the neostriatum of the rat as demonstrated in vivo by the push-pull perfusion technique: dependence on sodium but not calcium ions.
Sirinathsinghji DJ; Heavens RP; McBride CS
Brain Res; 1988 Mar; 443(1-2):101-16. PubMed ID: 3258784
[TBL] [Abstract][Full Text] [Related]
6. In vivo effect of MPTP on monoamine oxidase activity in mouse striatum.
Melamed E; Youdim MB; Rosenthal J; Spanier I; Uzzan A; Globus M
Brain Res; 1985 Dec; 359(1-2):360-3. PubMed ID: 3878183
[TBL] [Abstract][Full Text] [Related]
7. Neurotoxicity, drugs and abuse, and the CuZn-superoxide dismutase transgenic mice.
Cadet JL; Ali SF; Rothman RB; Epstein CJ
Mol Neurobiol; 1995; 11(1-3):155-63. PubMed ID: 8561959
[TBL] [Abstract][Full Text] [Related]
8. Immunity of fetal mice to prenatal administration of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
Melamed E; Rosenthal J; Youdim MB
J Neurochem; 1990 Oct; 55(4):1427-31. PubMed ID: 2398363
[TBL] [Abstract][Full Text] [Related]
9. Effect of serotonergic, corticostriatal and kainic acid lesions on the dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in mice.
Melamed E; Pikarski E; Goldberg A; Rosenthal J; Uzzan A; Conforti N
Brain Res; 1986 Dec; 399(1):178-80. PubMed ID: 3492237
[TBL] [Abstract][Full Text] [Related]
10. Transgenic mice with high levels of superoxide dismutase activity are protected from the neurotoxic effects of 2'-NH2-MPTP on serotonergic and noradrenergic nerve terminals.
Andrews AM; Ladenheim B; Epstein CJ; Cadet JL; Murphy DL
Mol Pharmacol; 1996 Dec; 50(6):1511-9. PubMed ID: 8967972
[TBL] [Abstract][Full Text] [Related]
11. Selective lesion of the nigrostriatal dopaminergic pathway by MPTP and acetaldehyde or diethyldithiocarbamate.
Zuddas A; Vaglini F; Fornai F; Corsini GU
Neurochem Int; 1992 Mar; 20 Suppl():287S-293S. PubMed ID: 1365444
[TBL] [Abstract][Full Text] [Related]
12. Acute electrophysiological and neurochemical effects of administration of MPTP in mice.
Studer A; Sundström E; Jonsson G; Schultz W
Neuropharmacology; 1988 Sep; 27(9):923-31. PubMed ID: 3263584
[TBL] [Abstract][Full Text] [Related]
13. Diethyldithiocarbamate potentiates the neurotoxicity of in vivo 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and of in vitro 1-methyl-4-phenylpyridinium.
Miller DB; Reinhard JF; Daniels AJ; O'Callaghan JP
J Neurochem; 1991 Aug; 57(2):541-9. PubMed ID: 1649252
[TBL] [Abstract][Full Text] [Related]
14. Enhanced N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity in mice deficient in CuZn-superoxide dismutase or glutathione peroxidase.
Zhang J; Graham DG; Montine TJ; Ho YS
J Neuropathol Exp Neurol; 2000 Jan; 59(1):53-61. PubMed ID: 10744035
[TBL] [Abstract][Full Text] [Related]
15. Suppression of MPTP-induced dopaminergic neurotoxicity in mice by nomifensine and L-DOPA.
Melamed E; Rosenthal J; Globus M; Cohen O; Uzzan A
Brain Res; 1985 Sep; 342(2):401-4. PubMed ID: 3876139
[TBL] [Abstract][Full Text] [Related]
16. Neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on striatal biopterin in BALB/c mice.
Lee EH
Neurosci Lett; 1988 Jun; 88(3):297-302. PubMed ID: 3260360
[TBL] [Abstract][Full Text] [Related]
17. Resistance to striatal dopamine depletion induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice expressing human mutant Cu,Zn superoxide dismutase.
Fornai F; Carrì MT; Ferri A; Paolucci E; Prisco S; Bernardi G; Rotilio G; Mercuri NB
Neurosci Lett; 2002 Jun; 325(2):124-8. PubMed ID: 12044637
[TBL] [Abstract][Full Text] [Related]
18. Dopamine but not norepinephrine or serotonin uptake inhibitors protect mice against neurotoxicity of MPTP.
Melamed E; Rosenthal J; Cohen O; Globus M; Uzzan A
Eur J Pharmacol; 1985 Oct; 116(1-2):179-81. PubMed ID: 3876943
[TBL] [Abstract][Full Text] [Related]
19. Sodium diethyldithiocarbamate protects against the MPTP-induced inhibition of immune responses in mice.
Renoux G; Bizière K; Renoux M; Steinberg R; Kan JP; Guillaumin JM
Life Sci; 1989; 44(12):771-7. PubMed ID: 2539542
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical evaluation of the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on dopaminergic nigrostriatal neurons of young adult mice using dopamine and tyrosine hydroxylase antibodies.
Mori S; Fujitake J; Kuno S; Sano Y
Neurosci Lett; 1988 Jul; 90(1-2):57-62. PubMed ID: 2901058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
